A 70-year-old man with chronic kidney disease stage 3 (eGFR 45 mL/min/1.73 m²) and diabetes is found to have albumin-creatinine ratio 40 mg/mmol. According to guideline-based care, which medication class should be prioritised to slow progression of kidney disease and reduce cardiovascular risk, assuming no contraindications?